These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Frequencies of hepatitis B, delta and human immune deficiency virus markers in multitransfused Saudi patients with thalassaemia and sickle-cell disease. el-Hazmi MA; Ramia S J Trop Med Hyg; 1989 Feb; 92(1):1-5. PubMed ID: 2918572 [TBL] [Abstract][Full Text] [Related]
29. [Epidemiologic and clinical study of HIV infection in Cagliari]. Farci P; Lai ME; Orgiana G; Chessa L; Casula P; Arnone M; Bolasco P; Bolasco F; Altieri P; Balestrieri A Recenti Prog Med; 1987 Dec; 78(12):539-42. PubMed ID: 3502504 [No Abstract] [Full Text] [Related]
31. Sickle cell crisis treated by exchange transfusion. Treatment of two patients with heterozygous sickle cell syndrome. Green M; Hall RJ; Huntsman RG; Lawson A; Pearson TC; Wheeler PC JAMA; 1975 Mar; 231(9):948-50. PubMed ID: 1173102 [TBL] [Abstract][Full Text] [Related]
32. [Therapy for thalassemia and sickle-cell disease]. Dickerhoff R Dtsch Med Wochenschr; 2015 Nov; 140(22):1646. PubMed ID: 26536632 [No Abstract] [Full Text] [Related]
33. Endocrine function in thalassemia major. Canale VC; Steinherz P; New M; Erlandson M Ann N Y Acad Sci; 1974; 232(0):333-45. PubMed ID: 4369990 [No Abstract] [Full Text] [Related]
34. Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease. Mok Q; Underhill G; Wonke B; Aldouri M; Kelsey M; Jefferies D Arch Dis Child; 1989 Apr; 64(4):535-40. PubMed ID: 2526622 [TBL] [Abstract][Full Text] [Related]
35. Cross-sectional study of immunologic abnormalities in intravenous drug abusers on methadone maintenance in New York City. Grieco MH; Reddy MM; Fusillo CA; Sorrell SJ; Buimovici-Klein E; Gindi EJ; Brown DK; Saxinger WC; Weiss SH; Flaster ER AIDS; 1989 Apr; 3(4):235-7. PubMed ID: 2500957 [TBL] [Abstract][Full Text] [Related]
36. Thrombocytopaenia as the presenting feature of persistent generalised lymphadenopathy (PGL) in a one-year-old. Forsyth JS; Sharp RA; Ghosh S Scott Med J; 1987 Aug; 32(4):121-2. PubMed ID: 3672109 [TBL] [Abstract][Full Text] [Related]
37. Prophylactic transfusions of normal red blood cells during pregnancies complicated by sickle cell hemoglobinopathies. Cunningham FG; Pritchard JA; Mason R; Chase G Am J Obstet Gynecol; 1979 Dec; 135(7):994-1003. PubMed ID: 507138 [TBL] [Abstract][Full Text] [Related]
38. Introduction to a How I Treat series on sickle cell disease and thalassemia. Coates TD Blood; 2018 Oct; 132(17):1729-1730. PubMed ID: 30206114 [No Abstract] [Full Text] [Related]
39. Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development. Orgad S; Malone G; Zaizov R; Marinowitz U; McLane MF; Umiel T; Cohen IJ; Vogel R; Cohen-Avishai O; Ramot B AIDS Res Hum Retroviruses; 1987; 3(3):323-32. PubMed ID: 3124874 [TBL] [Abstract][Full Text] [Related]
40. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease. Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]